NO-generating compounds modify tumoritoxic effect of doxorubicin.
Kondakova
I V
IV
Institute of Oncology, Tomsk Research Center, Siberian Division of Russian Academy of Medical Sciences. oncology@info.tsu.ru
Zagrebel'naya
G V
GV
Choinzonov
E Ts
ETs
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism / Q000627:therapeutic use; D017209:Apoptosis / Q000502:physiology; D001120:Arginine / Q000378:metabolism; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004247:DNA / Q000096:biosynthesis; D004317:Doxorubicin / Q000378:metabolism / Q000627:therapeutic use; D051379:Mice; D008810:Mice, Inbred C57BL; D009569:Nitric Oxide / Q000378:metabolism*; D020030:Nitric Oxide Donors / Q000378:metabolism; D009599:Nitroprusside / Q000378:metabolism; D012977:Sodium Nitrite / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D020030:Nitric Oxide Donors; D009599:Nitroprusside; D009569:Nitric Oxide; D004317:Doxorubicin; D004247:DNA; D001120:Arginine; D012977:Sodium Nitrite